We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Beta Cell Function in Women With Turner Syndrome

This study has been terminated.
(Completed)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00419107
First Posted: January 8, 2007
Last Update Posted: November 8, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Aarhus
  Purpose
Diabetes is more frequent in women with Turner syndrome. The purpose of this study is to see, in what ways the glucose metabolism is different in this study population. The hypothesis is that women with Turner Syndrome have an impaired insulin production (beta cell function).

Condition
Turner Syndrome

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Beta Cell Function in Women With Turner Syndrome

Resource links provided by NLM:


Further study details as provided by University of Aarhus:

Biospecimen Retention:   Samples With DNA
Blood samples.

Enrollment: 25
Study Start Date: November 2004
Study Completion Date: January 2007
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
13 women with TS and 12 control women
Criteria

Inclusion Criteria:

  • Turner syndrome

Exclusion Criteria:

  • Diagnosed diabetes
  • BMI>30
  • Untreated cardiac or thyroid disease
  • Cancer illness
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00419107


Locations
Denmark
Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital
Aarhus, Aarhus C, Denmark, 8000
Sponsors and Collaborators
University of Aarhus
Investigators
Principal Investigator: Jens Sandahl Christiansen, prof. dr.med
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Jens Sandahl Christiansen, Aarhus University Hospital, Aarhus, Denmark
ClinicalTrials.gov Identifier: NCT00419107     History of Changes
Other Study ID Numbers: 20040108
First Submitted: January 5, 2007
First Posted: January 8, 2007
Last Update Posted: November 8, 2011
Last Verified: November 2011

Additional relevant MeSH terms:
Turner Syndrome
Gonadal Dysgenesis
Primary Ovarian Insufficiency
Syndrome
Disease
Pathologic Processes
Disorders of Sex Development
Urogenital Abnormalities
Sex Chromosome Disorders of Sex Development
Heart Defects, Congenital
Cardiovascular Abnormalities
Cardiovascular Diseases
Heart Diseases
Congenital Abnormalities
Sex Chromosome Disorders
Chromosome Disorders
Genetic Diseases, Inborn
Gonadal Disorders
Endocrine System Diseases
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female


To Top